Systematic Review

Published on 22 Mar 2023

Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Qiran Wei
Jiting Zhou
Hongchao Li
Luying Wang
Yao Wu
Aixia Ma
Xin Guan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156081

4,208 views
6 citations

Original Research

Published on 20 Mar 2023

Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis

in Drugs Outcomes Research and Policies

Xi Chen
Mingye Zhao
Lei Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119906

3,576 views

Original Research

Published on 20 Mar 2023

The effect of parecoxib sodium on postoperative delirium in elderly patients with hip arthroplasty

in Drugs Outcomes Research and Policies

Jin-Huo Wang
Tong Liu
Yu Bai
Yong-Quan Chen
Ying-Hui Cui
Xin-Yue Gao
Jian-Rong Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.947982

2,326 views
7 citations

Original Research

Published on 17 Mar 2023

Prevalence and associated factors of medication adherence among infertile women undergoing frozen-thawed embryo transfer cycle: A cross-sectional study

in Drugs Outcomes Research and Policies

Ying Ni
Chenye Tong
Lianying Xu
Wen Qian
Limin Huang
Aijun Zhang
Qiong Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1148867

2,033 views

Original Research

Published on 09 Mar 2023

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Changchun Jian
Hai Mou
Ye Zhang
Qingxin Fan
Yunsheng Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1094834

2,814 views
5 citations

Original Research

Published on 09 Mar 2023

Factors influencing medication adherence in multi-ethnic Asian patients with chronic diseases in Singapore: A qualitative study

in Drugs Outcomes Research and Policies

Sungwon Yoon
Yu Heng Kwan
Wei Liang Yap
Zhui Ying Lim
Jie Kie Phang
Yu Xian Loo
Junjie Aw
Lian Leng Low

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124297

14,781 views
15 citations

Brief Research Report

Published on 09 Mar 2023

Phenotypic patient profiling for improved implementation of guideline-directed medical therapy: An exploratory analysis in a large real-world chronic heart failure cohort

in Drugs Outcomes Research and Policies

Sumant P. Radhoe
Pascal R. D. Clephas
Gerard C. M. Linssen
Remko M. Oortman
Frank J. Smeele
Annemarie A. Van Drimmelen
Henk-Jan Schaafsma
Paul H. Westendorp
Hans-Peter Brunner-La Rocca
Jasper J. Brugts

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1081579

2,835 views
4 citations

Original Research

Published on 09 Mar 2023

Validation of a scale to assess adherence to oral chemotherapy based on the experiences of patients and healthcare professionals (EXPAD-ANEO)

in Drugs Outcomes Research and Policies

Amparo Talens
Elsa LÓpez-Pintor
Mercedes Guilabert
Natalia Cantó-Sancho
María Teresa Aznar
Blanca Lumbreras

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1113898

3,295 views
1 citation

Original Research

Published on 08 Mar 2023

Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022

in Drugs Outcomes Research and Policies

Jia Liu
Yue Yu
Mingkang Zhong
Chunlai Ma
Rong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138996

3,539 views
3 citations

Original Research

Published on 03 Mar 2023

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab

in Drugs Outcomes Research and Policies

Maciej Niewada
Tomasz Macioch
Magdalena Konarska
Aneta Mela
Adam Goszczyński
Bogusława Przekopińska
Karolina Rajkiewicz
Piotr Wysocki
Maciej Krzakowski

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063178

5,438 views
4 citations

Original Research

Published on 02 Mar 2023

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Tianyang Hu
Yiting Liu
Yake Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.925375

2,284 views

Perspective

Published on 02 Mar 2023

China’s drug clinical trial institution record-keeping system: Qualification requirements for PI are the key

in Drugs Outcomes Research and Policies

Nanqu Huang
Wendi Huang
Yong Luo
Juan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1052977

2,084 views
1 citation

Original Research

Published on 02 Mar 2023

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China

in Drugs Outcomes Research and Policies

Shixian Liu
Lei Dou
Shunping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1055727

3,910 views
11 citations

Editorial

Published on 02 Mar 2023

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022

in Drugs Outcomes Research and Policies

Rachel M. A. Linger
Joseph O. Fadare
Ye Shen
Lon J. Van Winkle

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162703

918 views

Original Research

Published on 02 Mar 2023

A national survey of individualized pharmaceutical care practice in Chinese hospitals in 2019

in Drugs Outcomes Research and Policies

Mingyuan Cai
Liang Zhou
Daihui Gao
Dan Mei
Bo Zhang
Wei Zuo
Qing Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1022134

2,381 views
3 citations

Policy and Practice Reviews

Published on 28 Feb 2023

Access to medicines for rare diseases: A European regulatory roadmap for academia

in Drugs Outcomes Research and Policies

Noa Rosenberg
Sibren van den Berg
Nina N. Stolwijk
Bart A. W. Jacobs
Hendrika C. Post
Anna M. G. Pasmooij
Saco J. de Visser
Carla E. M. Hollak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1142351

7,801 views
3 citations

Navigation group

Articles

Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis

Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis

The effect of parecoxib sodium on postoperative delirium in elderly patients with hip arthroplasty

Prevalence and associated factors of medication adherence among infertile women undergoing frozen-thawed embryo transfer cycle: A cross-sectional study

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials

Factors influencing medication adherence in multi-ethnic Asian patients with chronic diseases in Singapore: A qualitative study

Phenotypic patient profiling for improved implementation of guideline-directed medical therapy: An exploratory analysis in a large real-world chronic heart failure cohort

Validation of a scale to assess adherence to oral chemotherapy based on the experiences of patients and healthcare professionals (EXPAD-ANEO)

Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma—A network meta-analysis. Focus on cabozantinib combined with nivolumab

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis

China’s drug clinical trial institution record-keeping system: Qualification requirements for PI are the key

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022

A national survey of individualized pharmaceutical care practice in Chinese hospitals in 2019

Access to medicines for rare diseases: A European regulatory roadmap for academia